Long-Term Follow-up of Humanized and Murine CD19 CAR-T Cell Therapy for B-Cell Malignancies

被引：0
|
作者：
Zhang, Yinqiang [1 ,2 ]
Du, Mengyi [1 ,2 ]
Liao, Danying [1 ,2 ]
Xie, Wei [1 ,2 ]
Xiong, Wei [3 ]
Mei, Heng [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Peoples R China
[2] Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China
[3] Wuhan Sian Med Technol Co Ltd, Wuhan, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180440
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia
    都孟仪
    ChinaMedicalAbstracts(InternalMedicine), 2024, 41 (01) : 59 - 60
  • [2] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [3] Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy
    Zhao, Yu
    Zhang, Jianping
    Yang, Junfang
    Wu, Huantong
    Chen, Yao
    Li, Nannan
    Liu, Zhongfeng
    Wang, Xuan
    Liu, Weihua
    Zhang, Guangji
    Zhou, Bin-Bing Stephen
    Lu, Peihua
    Chen, Zhiguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Long-Term Follow-Up of Anti-CD19 CAR T-Cell Therapy for B-Cell Lymphoma and Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 8 - 9
  • [5] Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
    Park, Jae H.
    Riviere, Isabelle
    Gonen, Mithat
    Wang, Xiuyan
    Senechal, Brigitte
    Curran, Kevin J.
    Sauter, Craig
    Wang, Yongzeng
    Santomasso, Bianca
    Mead, Elena
    Roshal, Mikhail
    Maslak, Peter
    Davila, Marco
    Brentjens, Renier J.
    Sadelain, Michel
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05): : 449 - 459
  • [6] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences), 2023, 66 (04) : 754 - 770
  • [7] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences) , 2023, (04) : 754 - 770
  • [8] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Chen, Zhaoqi
    Liu, Yan
    Chen, Nianci
    Xing, Haiyan
    Tian, Zheng
    Tang, Kejing
    Rao, Qing
    Xu, Yingxi
    Wang, Ying
    Wang, Min
    Wang, Jianxiang
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (04) : 754 - 770
  • [9] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China Life Sciences, 2023, 66 : 754 - 770
  • [10] Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia.
    Cappell, Kathryn
    Sherry, Richard Mark
    Yang, James C.
    Goff, Stephanie L.
    Vanasse, Danielle
    McIntyre, Lori
    Rosenberg, Steven A.
    Kochenderfer, James N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345